
Home
Chapter Home
Jobs
Conferences
Fellowships
Books
Advertisement
Breast malignant, males, children
Carcinoma subtypes
Intracystic (encysted) papillary carcinoma
Reviewer: Monika Roychowdhury, M.D., (see Reviewers
page)
Revised: 10 October 2012, last major update August 2012
Copyright: (c) 2001-2012, PathologyOutlines.com, Inc.
Terminology
=========================================================================
● Also called encapsulated papillary carcinoma, intracystic papillary ductal carcinoma in situ
Epidemiology
=========================================================================
● Rare, usually seen in elderly women
● 0.5-1% of all breast cancers
● May be associated with conventional DCIS or invasive carcinoma
Clinical description
=========================================================================
● Asymptomatic or presents as breast mass or nipple discharge
● Benign appearance on imaging; on ultrasonography, pure cyst, mixed image or solid mass
● Can be divided into pure form and those associated with ductal carcinoma in situ (DCIS) or invasive carcinoma
● Considered noninvasive or minimally invasive, because there is no infiltrating growth pattern and metastases are rare
● Traditionally considered to lack a myoepithelial layer
(Am J Clin Pathol 2005;123:36), but one study found expression of type IV collagen
(Am J Clin Pathol 2009;131:228)
● More difficult to diagnose preoperatively than other breast tumors
(Surg Today 2009;39:5)
● Pseudo-invasion may be due to prior core biopsy causing epithelial displacement
(J Clin Pathol 2002;55:780)
Case reports
=========================================================================
● 44 year old man
(J Med Case Reports 2009;13:13)
● 58 year old woman with solid variant
(Eur J Gynaecol Oncol 2008;29:545)
● 64 year old man with microinvasive tumor
(Breast Cancer 2010;17:146)
● Micrometastases in lymph nodes
(Int J Surg Pathol 2007;15:143)
● 3 case (Case Rep Obstet Gynecol 2012;2012:979563)
Treatment
=========================================================================
● Favorable prognosis
(Am J Surg Pathol 2006;30:1002), even with invasion
(Cancer 2008;113:916,
Hum Pathol 1998;29:1097)
● Stromal invasion in 92% with high nuclear grade, frequent mitotic activity, cyclin D1+ or p53+ (Breast J 2005;11:2)
● Treatment is similar to that of DCIS
(Am J Surg Pathol 2006;30:1002), namely excision, with possible adjuvant radiation or endocrine therapy
(Am J Surg 2007;194:497)
Gross description
=========================================================================
● Mural nodule within a large cystic space; may be encapsulated
Gross images
=========================================================================
Intracystic hemorrhagic tumor with invasion
Thick walled cyst in cystic space
Well defined fibrous margin
Micro images
=========================================================================
Papillary tumors
Classic features
Encapsulated tumor with hemorrhage
Papillary and solid pattern of atypical cells
Focal invasion
Core biopsy with luminal calcifications
CK 5/6 negative
Pseudoinvasion due to epithelial displacement post-biopsy
Virtual slides
=========================================================================
Intracystic papillary carcinoma
Positive stains
=========================================================================
● Type IV collagen in one study
(Am J Clin Pathol 2009;131:228)
Negative stains
=========================================================================
● CK 5/6, myoepithelial markers except for type IV collagen
End of Breast malignant, males, children > Carcinoma subtypes > Intracystic (encysted) papillary carcinoma
This information is intended for physicians and related personnel, who understand that medical information is often imperfect, and must be interpreted in the context of a patient's clinical data using reasonable medical judgment. This website should not be used as a substitute for the advice of a licensed physician.
All information on this website is protected by copyright of PathologyOutlines.com, Inc. Information from third parties may also be protected by copyright. Please contact us at copyrightPathOut@gmail.com
with any questions (click here for other
contact information).